The 'Heal Squad' podcast host, whose pancreatic cancer was discovered early enough to be treated, says, "I wouldn't be here ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

A blood test for more than 50 types of cancer could help speed up diagnosis according to a new study. Results of a trial in ...

Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

Emory researchers discovered blood changes that could allow Alzheimer’s to be detected years before symptoms appear. The team is developing a blood test that may identify early risk and guide ...

People who develop rheumatoid arthritis experience changes to their immune systems long before their joints become swollen and painful, suggesting that early treatment might stop or limit damage, a ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Our bodies do not age at a uniform rate. The speed at which one organ ages can differ greatly from another due to a range of lifestyle, environmental and genetic factors. Conventional tests provide a ...

Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is a world-first protein biomarker-based blood diagnostic that can rule out ...

“A blood test is easier than a lumbar puncture, which is needed for CSF [cerebral spinal fluid], which is one of the ways in which Alzheimer’s disease can be detected,” Marquez said. “The other way is ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...